spacer
home > ict > autumn 2018 > streamlining start-ups
PUBLICATIONS
International Clinical Trials

Streamlining Start-Ups

New life sciences industry research reveals significant momentum towards streamlining clinical systems and processes over the past year. More than 300 clinical operations professionals from around the globe were surveyed in an annual unified clinical operations survey to track the industry’s progress in improving clinical operations. Nearly all clinical leaders (99%) recognise the need to unify their clinical operating environments, and most (87%) have plans in place to get there.

Better Visibility and Faster Trial Execution

The widespread move to unify clinical environments is being driven by application and process silos that have resulted from the steady adoption of function-specific clinical technologies over the past decade. Stand-alone eClinical applications, including electronic data capture, electronic trial master files (eTMFs), randomisation and trial supply management, and clinical trial management systems (CTMSs) are now the norm. Newer, purpose-built applications, such as study start-up, are gaining traction (1).

Faced with a landscape of disparate systems and processes, over three quarters (77%) of those surveyed find better visibility across their clinical trial processes a top driver for unifying clinical applications. Other primary drivers include faster study execution (67%), improved study quality (62%), and increased productivity (51%).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Rik Van Mol is Vice President of R&D Strategy at Veeva Systems, responsible for the Veeva Vault R&D suite of applications in Europe. Rik has nearly 20 years of experience in business/IT consulting and has regulated content management in the life sciences sector. His experience has been built on assisting clients through complex transformational programmes across the life sciences value chain, including clinical, regulatory, and manufacturing/supply chain areas for some of the world’s largest companies.
spacer
Rik Van Mol
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm accelerates strategy to broaden service offering into commercial manufacturing

MedPharm Ltd, a leading contract provider of topical and transdermal product design and development services, has announced two new appointments to its Board to support plans to grow its commercial manufacturing services.
More info >>

White Papers

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Myoderm

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement